(CFR) Cullen/Frost Bankers - Overview
Stock: Loans, Deposits, Treasury Management, Trust Services, Insurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.07% |
| Yield on Cost 5y | 5.75% |
| Yield CAGR 5y | 7.66% |
| Payout Consistency | 81.8% |
| Payout Ratio | 39.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.8% |
| Relative Tail Risk | -9.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -7.91 |
| Character TTM | |
|---|---|
| Beta | 0.966 |
| Beta Downside | 1.146 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.96% |
| CAGR/Max DD | 0.20 |
Description: CFR Cullen/Frost Bankers January 07, 2026
Cullen/Frost Bankers, Inc. (NYSE:CFR) is the holding company for Frost Bank, a Texas-based institution that delivers a full suite of commercial and consumer banking services. Its commercial portfolio includes financing for industrial and commercial real-estate projects, equipment, inventory, accounts-receivable, and acquisitions, plus treasury-management solutions. On the consumer side, the bank offers checking and savings accounts, a network of ATMs, overdraft protection, mortgage and home-equity products, as well as brokerage and safe-deposit services.
The firm also provides international banking (deposits, loans, letters of credit, foreign exchange), correspondent-banking functions (check clearing, fund transfers, securities custody), and a range of trust, investment, and capital-markets capabilities such as sales-trading, underwriting, and advisory services. Its client base spans energy, manufacturing, construction, retail, telecom, healthcare, military, and transportation sectors.
Key recent metrics (as of Q4 2023): a CET1 capital ratio of ~13.1%, net interest margin of 3.45%, loan growth of 5.2% YoY, and return on equity (ROE) of 13.8%. Deposit balances have risen 4.8% YoY, reflecting strong Texas consumer confidence, while loan-to-deposit ratios remain comfortably below 80%.
Sector drivers that materially affect CFR include the Federal Reserve’s policy rate trajectory (which influences net interest margin), Texas’s robust population growth (fueling retail and mortgage demand), and the cyclical health of the energy sector (a major borrower segment). A slowdown in oil prices could pressure loan-loss provisions, whereas a higher-for-longer rate environment tends to expand net interest income for regional banks.
For a deeper quantitative breakdown, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 648.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -1.20 > 1.0 |
| NWC/Revenue: -1106 % < 20% (prev -765.9%; Δ -339.9% < -1%) |
| CFO/TA 0.01 > 3% & CFO 367.2m > Net Income 648.6m |
| Net Debt (-681.3m) to EBITDA (837.7m): -0.81 < 3 |
| Current Ratio: 0.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.6m) vs 12m ago -0.99% < -2% |
| Gross Margin: 79.54% > 18% (prev 0.70%; Δ 7883 % > 0.5%) |
| Asset Turnover: 5.22% > 50% (prev 5.43%; Δ -0.21% > 0%) |
| Interest Coverage Ratio: 0.84 > 6 (EBITDA TTM 837.7m / Interest Expense TTM 684.6m) |
Altman Z'' -3.34
| A: -0.57 (Total Current Assets 16.65b - Total Current Liabilities 47.11b) / Total Assets 53.04b |
| B: 0.08 (Retained Earnings 4.31b / Total Assets 53.04b) |
| C: 0.01 (EBIT TTM 573.7m / Avg Total Assets 52.78b) |
| D: 0.09 (Book Value of Equity 4.31b / Total Liabilities 48.47b) |
| Altman-Z'' Score: -3.34 = D |
What is the price of CFR shares?
Over the past week, the price has changed by +5.78%, over one month by +8.34%, over three months by +19.32% and over the past year by +9.47%.
Is CFR a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 9
- Sell: 0
- StrongSell: 2
What are the forecasts/targets for the CFR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 144.2 | -2% |
| Analysts Target Price | 144.2 | -2% |
| ValueRay Target Price | 156.5 | 6.4% |
CFR Fundamental Data Overview February 09, 2026
P/E Forward = 15.2672
P/S = 4.2808
P/B = 2.0939
P/EG = 2.6079
Revenue TTM = 2.75b USD
EBIT TTM = 573.7m USD
EBITDA TTM = 837.7m USD
Long Term Debt = 223.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.60b USD (from shortTermDebt, two quarters ago)
Debt = 4.82b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -681.3m USD (from netDebt column, last fiscal year)
Enterprise Value = 5.33b USD (9.38b + Debt 4.82b - CCE 8.86b)
Interest Coverage Ratio = 0.84 (Ebit TTM 573.7m / Interest Expense TTM 684.6m)
EV/FCF = 23.04x (Enterprise Value 5.33b / FCF TTM 231.5m)
FCF Yield = 4.34% (FCF TTM 231.5m / Enterprise Value 5.33b)
FCF Margin = 8.40% (FCF TTM 231.5m / Revenue TTM 2.75b)
Net Margin = 23.54% (Net Income TTM 648.6m / Revenue TTM 2.75b)
Gross Margin = 79.54% ((Revenue TTM 2.75b - Cost of Revenue TTM 563.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 75.18%)
Tobins Q-Ratio = 0.10 (Enterprise Value 5.33b / Total Assets 53.04b)
Interest Expense / Debt = 3.42% (Interest Expense 164.9m / Debt 4.82b)
Taxrate = 16.03% (31.7m / 198.0m)
NOPAT = 481.8m (EBIT 573.7m * (1 - 16.03%))
Current Ratio = 0.35 (Total Current Assets 16.65b / Total Current Liabilities 47.11b)
Debt / Equity = 1.05 (Debt 4.82b / totalStockholderEquity, last quarter 4.57b)
Debt / EBITDA = -0.81 (Net Debt -681.3m / EBITDA 837.7m)
Debt / FCF = -2.94 (Net Debt -681.3m / FCF TTM 231.5m)
Total Stockholder Equity = 4.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.23% (Net Income 648.6m / Total Assets 53.04b)
RoE = 14.95% (Net Income TTM 648.6m / Total Stockholder Equity 4.34b)
RoCE = 12.58% (EBIT 573.7m / Capital Employed (Equity 4.34b + L.T.Debt 223.0m))
RoIC = 10.91% (NOPAT 481.8m / Invested Capital 4.41b)
WACC = 7.24% (E(9.38b)/V(14.20b) * Re(9.48%) + D(4.82b)/V(14.20b) * Rd(3.42%) * (1-Tc(0.16)))
Discount Rate = 9.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.45%
[DCF Debug] Terminal Value 78.79% ; FCFF base≈483.6m ; Y1≈415.5m ; Y5≈324.9m
Fair Price DCF = 119.9 (EV 6.90b - Net Debt -681.3m = Equity 7.58b / Shares 63.2m; r=7.24% [WACC]; 5y FCF grow -17.11% → 2.90% )
EPS Correlation: 45.19 | EPS CAGR: 18.11% | SUE: 3.29 | # QB: 5
Revenue Correlation: 70.91 | Revenue CAGR: 13.81% | SUE: -0.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.49 | Chg30d=+0.098 | Revisions Net=+11 | Analysts=12
EPS current Year (2026-12-31): EPS=10.16 | Chg30d=+0.323 | Revisions Net=+11 | Growth EPS=-0.7% | Growth Revenue=+2.2%
EPS next Year (2027-12-31): EPS=10.41 | Chg30d=+0.367 | Revisions Net=+11 | Growth EPS=+2.5% | Growth Revenue=+4.7%